Neutrogena Appears in 57.2% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Answer Capsule

In November 2026, Neutrogena appeared in 442 of 773 AI answers included in the Dermatologist Recommended Skin Care Brands benchmark (57.18%). It received 242 recommendations (31.31%), with 76 Top 3 placements and 18 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

• How do Neutrogena mentions, recommendations and placements compare with its Dermatologist Recommended Skin Care Brands peers?

Neutrogena recorded 442 mentions (57.18%) and 242 recommendations (31.31%) across 773 answers included in the benchmark. Top 3 placements numbered 76; first-place recommendations numbered 18. Framing among its mentions was 263 positive, 178 neutral and 1 negative.

Neutrogena appears in a clear majority of the answers reviewed, and it is recommended in a meaningful share of them. That reach is real, but it sits well behind the leading brands on both counts, so the brand is part of the conversation without being the default answer.

The gap widens when position is considered. Recommendations are frequent enough, yet placements near the top of a list are comparatively rare, and first-place finishes rarer still. Being named is not the same as being chosen first, and the agency would treat those as separate goals.

Wording around the brand is mostly positive or neutral, with almost no negative framing. The practical opportunity is therefore not reputation repair but strengthening how firmly and how early the brand is endorsed when answers compare options.

What changed since last month

Questions This Section Answers

• How did Neutrogena counts and coverage differ across the available monthly snapshots?

From October 2026 to November 2026, Neutrogena's mention count rose from 410 to 442, while its recommendation count fell from 387 to 242. The recommendation rate was 50.26% and 31.31% respectively.

Across the recent monthly samples, mentions moved within a fairly narrow band, dipping and then recovering. Recommendations, by contrast, fell sharply in the latest month after holding steadier earlier. The two measures are moving differently, which is worth watching closely.

Placements near the top of a list also dropped in the latest month, while first-place finishes recovered somewhat from the prior low. These are separate selected samples, and the answers included differ between months, so the movements should be read as observations rather than a trend with a known cause.

The agency would keep tracking mentions, recommendations and position side by side rather than treating any single month as a verdict. A sustained pattern over several months would be more informative than one reading.

Step 1. Measure

Questions This Section Answers

• What should the agency measure and verify first for Neutrogena?

AI answers contained 0 conflicting claims about Neutrogena: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about Neutrogena were recorded in the captured answers, so there is no fact-check queue to work through at present. That is a clean starting position, but it reflects what the answers said, not proof that every statement about the brand is accurate.

The useful first step is a visibility scorecard that sets reach, recommendation and position against the leading brands, so priorities rest on a shared view rather than a single number. Alongside it, the agency would keep a standing list of brand claims worth verifying if any appear later.

This pairing lets the client decide where to invest effort: closing the recommendation gap, improving placement, or protecting existing strength.

Step 2. Make the website consistent

Questions This Section Answers

• Which recorded claim differences about Neutrogena should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No disputed topics were supplied for this part of the analysis, so there is nothing to resolve or correct at this stage. The agency would not invent conflicts where none were recorded.

If claims do surface later, the first move is verification against current primary sources, including product names, dates and the exact wording used. An apparent conflict can often reflect different dates or different product versions rather than an error by anyone.

Only after that check would the agency propose a page brief, and only where the verified facts support a change. Ambiguous matches would stay out of any correction queue.

Step 3. Align the external narrative

Questions This Section Answers

• Which cited third-party pages are relevant to fact review for Neutrogena?

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review span a trade publication, retailer listings, a professional brand page and a regional site. None of them is linked to a conflicting claim, so this is a relevance review rather than a repair list. Their current contents still need checking before any request is made.

The agency would review each source for how it describes the brand and its products, then decide whether an evidence-backed update is worth requesting. A citation does not show that a page shaped an answer, and publishers are not assumed to be at fault.

Requests would be framed around verified facts, with responses logged separately from confirmed edits and no-change decisions.

Step 4. Optimize priority company pages

Questions This Section Answers

• Which observed Neutrogena website pages should receive review briefs?

The company's website was cited 5 times across 4 distinct page addresses; the table shows 4 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The brand's own pages were cited a handful of times across a small set of addresses, and only one of those citations appeared alongside a recommendation. That page, which makes the dermatologist-recommended case, is the natural starting point for a page brief.

The other cited pages cover specific products, including the fragrance-free acne wash and the clear-face sunscreen. Briefs for these would draw on approved facts and the questions buyers actually ask, checking existing coverage before proposing anything new.

A cited page is not automatically a page that drove a recommendation, so the agency would treat these as candidates for strengthening rather than proven gaps.

Step 5. Publish around buyer questions

Questions This Section Answers

• Which observed buyer questions support content briefs for Neutrogena?

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster around brand rankings, moisturizer choice, comedones, facial cleanser and non-comedogenic options for people on Accutane. Neutrogena was mentioned in nearly all of them and recommended in most, which suggests the brand is already in the consideration set for these topics.

These are answer observations, not search volume or proof that the website lacks content. The agency would check existing pages first, then draft briefs only where coverage is thin or unclear.

Priority would go to the questions where the brand is mentioned but not recommended, since those are the places where clearer, evidence-backed content could plausibly help.

Our 90-day action plan

Questions This Section Answers

• How should the agency sequence the proposed Neutrogena work and judge completion?

The first month establishes the baseline: a visibility scorecard, a scoped fact-review register and a shortlist of pages and sources. Each record gets an owner, an evidence requirement and a review status, so later work rests on a shared record.

The second month turns that into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions, requests and responses kept separate. The third month adds buyer-content briefs and a fresh scorecard.

Delivered work is recorded separately from measured answer outcomes. Completing a brief or sending a request does not establish that visibility improved, and the comparability limits of each monthly sample remain in view.

Methodology

Questions This Section Answers

• How are Neutrogena answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 773 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5811 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The report covers a single month, and the exact dates when the original answers were collected have not been verified. Rates rest on the answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording.

An answer can mention or recommend several companies, so company counts cannot be added to find distinct answers. Sentiment describes answer wording, not customer satisfaction. The wider citation review covers more answers than the benchmark, and cited pages still need independent checking.

Monthly samples differ, so comparisons show how recorded results changed, not why.

Our first three priorities

The first priority is a visibility scorecard that separates reach, recommendation and position against the leading brands. Neutrogena is mentioned often but recommended less often and placed near the top rarely, so the client needs to see those three measures distinctly before choosing where to focus.

The second is a page brief for the dermatologist-recommended page, built on approved facts and the questions buyers ask, with existing coverage checked first. The third is a source review of the cited trade and retailer pages, followed by evidence-backed requests only where verification supports them.

Fact-checking stays light while no conflicting claims are recorded, but the register should remain open. Progress would be judged by work completed and by later scorecards, not by promised gains.